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We evaluated the preventive and therapeutic effects of aqueous suspensions of garlic, tomato, and garlic + tomato in the development
of experimental Ehrlich tumors in mice. The aqueous suspensions (2%) were administered over a short term for 30 days before
tumor inoculation and 12 days afterward, and suspensions at 6% were administered for 180 days before inoculation and for 12 days
afterward.The volume, number, and characteristics of the tumor cells andAgNOR counts were determined to compare the different
treatments. Aqueous 6% suspensions of garlic, tomato, and garlic + tomato given over the long term significantly reduced tumor
growth but when given over the short term, they did not alter tumor growth.
1. Introduction
Cancer is a disease of complex etiology. It is now recognized
that a great majority of human cancers, perhaps as many as
80–90%, are attributable to environmental factors [1]. A num-
ber of these factors, such as the association between smoking
and lung cancer, a high-fat diet with breast and colon cancer,
and several other malignancies, have been identified [2, 3].
The transformation of normal cells to cancerous involves
three distinct phases: initiation, promotion, and progression
[4]. Dietary habits are known to modify each of these phases
[5]. Plants contain an extensive variety of compounds, some
of which are strong modifiers of chemical carcinogenesis [6].
The prevention of cancer through the ingestion of vegetables
and fruits has been suggested in human epidemiologic studies
[1, 6]. The induction of apoptosis is currently recognized as
a useful strategy to treat and prevent cancer, and a large
number of natural dietary constituents have been reported
to induce apoptosis in malignant cells [7, 8]. These findings
are consistent with the observation that high consumption of
fruits and vegetables is associatedwith reduced risk of various
cancers; in particular, tomato and garlic are recognized to
possess a wide range of beneficial effects [1, 9].
Garlic (bulb of Allium sativum), a common plant used as
a food item as well as a medicinal herb in many countries
of the world, is one of the most ancient plants reputed to
have cancerostatic effects, as well as antiviral, antifungal, and
antibacterial activities, and the ability to lower blood lipid lev-
els and blood pressure [1, 10]. Garlic contains at least thirty-
three sulfur compounds, several enzymes, and seventeen
amino acids. Additional constituents of intact garlic include
steroidal glycosides and lectins [1, 6]. The sulfur compounds
are responsible for garlic’s pungent odor and many of its
medicinal effects [11]. The anticarcinogenic properties of
garlic have been indicated in several studies [1, 12–14].
Beneficial effects of tomato (Lycopersicon esculentum)
were observed against cancer of the pancreas, colon, rectum,
esophagus, and breast [13, 15, 16]. Lycopene, which is found
in tomato-based products, belongs to the carotenoid family, a
group of more than 1000 plant and animal pigments involved
in photosynthesis and photoprotection. Lycopene may be
important in preventing prostate cancer [17, 18].
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Figure 1: Experimental design. Eight groups were constituted, that is, 2% or 6% garlic and/or tomato and an untreated group that received
only water. Animals receiving a 2% suspension were treated for 30 days, and those that received a 6% suspension were treated for 180 days.
Transplantable experimental tumors have been used in
studies of physical, chemical, viral, and hormonal carcino-
geneses. Ehrlich tumor is a transplantable neoplasm from
a malign epithelium, such as mammary adenocarcinoma in
female mice. When inoculated intraperitoneally, the tumor
grows in an ascitic form [19]. In this study, we compared
the effects of aqueous garlic and/or tomato suspensions
administered over a short and long term on the prevention
and treatment of experimental Ehrlich ascites tumors inmice.
2. Material and Methods
2.1. Bioactive Compounds. Garlic bulbs and tomato paste
(28∘ Brix, with 30.5mg/100 g of lycopene) were bought from
a local market (Sa˜o Paulo City, SP, Brazil). The dehusked
cloves of garlic were ground in a mortar and pestle, and the
formed paste was diluted with distilled water to make 2%
and 6% aqueous suspensions (w/v).The suspensions of garlic
were prepared fresh daily before oral administration [16]. To
prepare the tomato aqueous suspension, we mixed tomato
paste and distilled water to obtain 2% and 6% suspensions
(w/v). Finally, 2% and 6% aqueous suspensions of the two
components (garlic + tomato) were made by diluting garlic
and tomato paste in 200mL of distilled water.
2.2. Ehrlich Tumor. The Ehrlich ascites tumor was main-
tained in 3-month-old female BALB/c mice in ascitic form
under a week passage. In the experiment, the animals were
intraperitoneally (IP) injected with 5 × 107 viable tumor cells
suspended in 0.3mL of phosphate-buffered saline (PBS) or
the same volume of PBS (vehicle solution). The suspension
containing the tumor cells was prepared according to a
previous study [19, 20]. The ascitic fluid was collected by IP
puncture using a sterile insulin syringe. Ascites tumor cell
counts were performed using a Neubauer hemocytometer,
and the cells were found to be more than 99% viable by the
trypan blue dye exclusion method [20].
2.3. Animals. Adult female inbred BALB/c mice (8 weeks)
weighing 25.9 ± 2.4 g were housed in groups of five in a
ventilated caging system in a temperature- and humidity-
controlled facility with a 12 h light/dark cycle. The mice were
fed a balanced, commercial diet ad libitum. Experimentswere
carried out in compliance with the principles of International
Laboratory Animal Care and the European Communities
Council Directive (86/809/EEC) and were approved by the
local ethical committee.
2.4. Experimental Design. The animals were divided into
eight groups (𝑛 = 10 mice for group) to carry out two
independent experiments, the first with short term adminis-
tration of the compounds for 30 days and the second with the
long term administration of aqueous suspensions for 180 days
before tumor inoculation.The groups were formed according
to the type of treatment (Figure 1): garlic: received aqueous
garlic suspension (at 2% for 30 days or 6% for 180 days);
tomato: received aqueous tomato suspension (at 2% for 30
days or 6% for 180 days); garlic + tomato: received aqueous
garlic and tomato suspension (at 2% for 30 days or 6% for 180
days); control: received only water.The bioactive compounds
were prepared as described above and offered ad libitum as
the only source of water for the animals allocated in the garlic,
tomato, and garlic + tomato groups. The exchange of these
compounds was performed three times a week, and intake
of the bioactive compounds as well as water consumption
(control group) wasmeasured and recorded for later analysis.
All animalswereweighed once aweek to evaluateweight gain.
In the first experiment, the animals that received the 2%
aqueous suspension and the control group were inoculated
with experimental ascites Ehrlich’s carcinoma cells (0.3mL
of 5 × 107 cells, IP) on the 30th day, and they continued to
receive the bioactive compounds. On the 12th day after tumor
implantation, the animals were anesthetized, and the ascites
fluidwas collected for volume and cell number quantification.
In the second experiment, after 180 days of treatment, 3
groups that had received long term treatment with aqueous
suspensions and the control group were inoculated with
Ehrlich tumors as described for the short term treatment
groups.
2.5. Quantification and Qualification of Ehrlich Ascitic Tumor
Growth. For Ehrlich tumor growth evaluation, the ascitic
fluid present in the experimental and control mice was
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Table 1: Average parameters of the Ehrlich tumors in the experimental groups treated with aqueous suspensions of garlic, tomato, or garlic +
tomato over the short and long term.
Groups Ascitic volume(mL)
Solid mass
tumor (mL)
Number of cells
by mL (×108)
Total concentration of
tumor cells (cells ×108)
Number of
NORs/nuclei
Experiment 1
Garlic 2% 10.0 ± 1.95 3.2 ± 0.39 2.94 ± 0.89 11.58 ± 4.75 16.45 ± 1.95
Tomato 2% 11 ± 1.79 4.0 ± 0.36 3.52 ± 0.24 10.94 ± 5.65 14.85 ± 2.52
Garlic + tomato 2% 10.5 ± 2.11 3.9 ± 0.89 3.25 ± 0.44 10.96 ± 3.89 15.48 ± 2.23
Control 12 ± 1.90 4.1 ± 0.56 4.38 ± 0.95 12.47 ± 5.10 18.67 ± 2.83
Experiment 2
Garlic 6% 8.0 ± 1.15∗ 1.5 ± 0.39∗ 1.15 ± 0.25∗ 3.49 ± 0.86∗ 10.24 ± 1.45∗
Tomato 6% 10 ± 1.97 3.0 ± 0.26 1.97 ± 0.16∗ 6.03 ± 0.73∗ 12.46 ± 1.87∗
Garlic + tomato 6% 7.9 ± 2.31∗ 1.0 ± 1.17∗ 1.00 ± 0.11∗ 2.9 ± 1.60∗ 11.37 ± 1.55∗
Control 11 ± 2.43 4.2 ± 0.90 3.46 ± 1.50 13.8 ± 8.10 19.22 ± 2.95
Data are represented as the means ± SD. ∗𝑃 < 0.05 in comparison to the control group (one-way ANOVA and Tukey-Kramer post hoc test).
collected, the volume was measured, and the number of
tumor cells was counted in a Neubauer chamber using the
trypan blue dye exclusion method. The ascites fluid was
centrifuged for 10 minutes at 200 g, the supernatant was
discarded, and the solid volume was measured.
Smears from the cell suspension obtained from each
animal were carried out and then submitted to a panoptic
stain to determine the cell characteristics, dark cells/clear
cells ratio, nucleus/cytoplasm ratio, and mean diameter of
neoplasm cell nuclei using an immersion objective (1000x
magnification). The mean nucleus diameter was only evalu-
ated in mononucleated neoplasm cells.
The nucleolus organizer region was stained with silver
(AgNORs), in accordance with a technique described by
Ploton et al. [21] and modified by Aubele et al. [22]. Incu-
bation was carried out in a humid and dark chamber at
40∘C for 15minutes. Characterizing and counting the number
of AgNORs were carried out using an immersion objec-
tive. The number of cells and nuclei (to determine the
nucleus/cytoplasm ratio and the number of NORs) was
determined by studying the mean instability variation of the
sample from which they originated (1000x magnification).
The standard deviation and variation coefficient of the stud-
ied variables were approximately thirty cells/slide/animal.
2.6. Toxicity Study. Liver, kidney, lung, spleen, heart, and
intestine nodes were collected, and representative slices were
routinely processed for embedding in paraffin. Sections
(5-𝜇m) were stained in H&E and examined for possible
histopathological changes.
2.7. Statistical Analysis. The differences in mean values
among different groups were tested and expressed asmeans ±
SD. Statistical analysis was carried out using SPSS version
15.0 (Statistical Package for the Social Sciences, Chicago,
IL). Data were expressed as means ± SD, and values of
𝑃 < 0.05 were considered statistically significant. For the
animals’ body weights, the differences among groups were
verified by ANOVA, while differences of other variables were
investigated using ANOVA or the Kruskal-Wallis test (when
the data were not normally distributed).
3. Results
In the first experiment, when treating the animals for a
short period (30 days before inoculation and 12 days after
inoculation), we observed that tumor growth was the same in
all experimental groups, with no statistically significant dif-
ferences between animals treated with aqueous suspensions
of garlic, tomato, or garlic + tomato relative to the control.
We observed the mean volume of ascites tumors, solid tumor
mass, number of cells per mL, and the total number of tumor
cells but found no significant differences between the groups
(Table 1).
However, in the second experiment, we observed that
the groups administered aqueous suspensions of garlic and
garlic + tomato at 6% over the long term (180 days before
tumor inoculation and 12 days after inoculation) showed sig-
nificantly reduced tumor growth. The average volume of the
tumor ascites fluid, the volume of solid mass, the tumor cell
number per milliliter, and total tumor cells were significantly
lower in animals receiving the aqueous suspension of garlic
and garlic + tomato compared with the control group, which
received only water (Table 1).
Regarding the group treated with the aqueous tomato
suspension, although the average volume of fluid and of
the solid mass tumor showed no significant difference when
compared to the control group, the mean number of tumor
cells per mL and total tumor cells were significantly lower
than those of the control group.
In experiment 1, no statistically significant difference
between the mean AgNOR dots obtained for the groups was
observed, but, in experiment 2, groups treated with garlic,
tomato, and garlic + tomato had significantly lower mean
AgNOR dots (10.24 ± 1.45, 12.46 ± 1.87, and 11.37 ± 1.55, resp.)
than the control group (19.22 ± 2.95) (Table 1).
The characteristics of the Ehrlich tumor cells differed
among the groups. In the control group, a significantly
smaller number of dark cells were observed, and cells that
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Table 2: Mean weight gain for animals from the two experiments
before and after inoculation with an Ehrlich tumor.
Experimental groups
Mean weight gain
before inoculation
(g)
Mean weight gain
after inoculation
(g)
Garlic 5.00 ± 2.04 4.99 ± 2.1
Tomato 6.39 ± 1.66 4.11 ± 1.1
Garlic + tomato 3.54 ± 1.32∗ 3.80 ± 1.4
Control 5.15 ± 0.92 4.52 ± 1.3
∗Data are represented as the means ± SD. ∗𝑃 < 0.05 in comparison to the
control group (one-way ANOVA and Tukey-Kramer post hoc test).
were clear and roundwith abundant, eosinophilic, vacuolated
cytoplasm with few defined edges and large nuclei that were
sometimes multinucleated were predominant. In the group
treated with bioactive compounds, the opposite occurred;
that is, a significantly smaller number of clear cells with
predominance of dark cells were observed. Most cells were
round, with moderate, basophilic cytoplasm that had a few
vacuoles, defined edges, and hyperchromatic nuclei that
varied from oval to round.
Neoplastic cells from the control group presented cyto-
plasmic and nuclear volumes larger than those of the groups
treated with biocompounds. Morphometric analysis corrob-
orated the differences in cell and nucleus size among the
groups.
We observed that the garlic + tomato group had a
lower body gain when compared to other groups, that is,
garlic, tomato, and control, during the preinoculation period.
However, after the experimental inoculation with Ehrlich
tumors, there was no significant difference in weight gain
between the groups (Table 2). The consumption of bioactive
compounds did not significantly change relative to the water
intake. No evidence of hepatic or renal toxicity was found by
histopathological analysis.
4. Discussion
The beneficial anticarcinogenic and immunomodulatory
effects of the agents in garlic [23], that is, water- and lipid-
soluble allyl sulfides, can influence a number of molecular
events involved in cancer, such as inhibiting mutagenesis,
blocking carcinogen DNA adduct formation, scavenging free
radicals, and blocking cell proliferation, differentiation, and
angiogenesis. Although there is a large body of evidence
supporting each of these and other mechanisms, there is a
need for additional research to demonstrate whether these
changes are causally related to cancer-preventive activity.
Carotenoids found in tomatoes are fat-soluble pigments
responsible for the yellow, orange, and red colors in many
fruits and vegetables [14]. Lycopene has the strongest antioxi-
dant properties of the carotenoids, and higher intake has been
associated with a reduced risk of many cancer types, includ-
ing prostate, lung, and stomach [14, 15]. Recentwork in cancer
cell lines and animal models has demonstrated that lycopene
can reduce the transcription of steroid-related genes, insulin-
like growth factor-1 expression, and inflammatory signals,
suggesting that these pathways may account, in part, for the
inverse association between lycopene and the risk of some
cancers [24, 25].
We observed that the bioactive compounds in garlic
and/or tomato administered for a short period did not
prevent or reduce the development of experimental Ehrlich
ascites tumors in BALB/c mice. However, when we increased
the concentration of the aqueous garlic and/or tomato sus-
pension and administered the solution for a long period (for
6 months), the anticancer effects of garlic and/or tomato
were observed because the growth of the tumor was lower in
treated than in untreated animals.
The concentration of the compounds (2%) for the short
term treatment was based on the results of Sengupta et al.
[16], who also orally administered (by gavage) one milliliter
of aqueous garlic or tomato suspension at a concentration
of 2% for 12 weeks (84 days) prior to inducing experimental
colon tumors in rat. They observed that a mixture of garlic
and tomato was more effective in preventing colon cancer in
rats. In our experiment, the compounds were spontaneously
ingested by mice, although a difference in intake of the
product compared to water intake by the controls has not
been demonstrated. This difference in administration, as
cited by the authors, may be one reason for the lack of active
preventive compounds.
Carcinogenesis involves several stages: initiation, promo-
tion, and progression. Tumor cells originate from normal
cells that undergo changes in DNA (genetic) or mechanisms
that control gene expression (epigenetic factors) in one or
more location involved in controlling cell division and dif-
ferentiation.The results of Sengupta et al. [16] may also differ
fromours because theymost likely used a chemically induced
carcinogenesis model with clear phases of carcinogenesis
in which the bioactive compounds act, while we used a
tumor model in which cancer cells are transplanted and only
progress.
When we increased the concentration of the compounds
and administered them for an extended time (long term),
the results showed that the animals treated with garlic,
tomato, or garlic + tomato exhibited less tumor growth,
demonstrating the preventive effects of biocompounds when
given spontaneously in drinking water.
Ehrlich tumors are rapidly growing carcinomas with
aggressive behavior.They are able to grow in nearly all mouse
strains, which suggests that the recognition and immune
responses to these tumors are independent of the MHC
[26]. This characteristic suggests that controlling an Ehrlich
tumor is more related to innate immunity, especially the
inflammatory response, than to T cell responses [27]. The
Ehrlich ascites tumor implantation induces per se a local
inflammatory reaction, with increasing vascular permeabil-
ity, which results in the formation of an intense edema and
progressive ascites fluid and cellular migration [28]. This
effect ismost likely related to angiogenesis and growth factors
that are induced by inflammation and necessary for tumor
development.
Following treatment with a 2.5% aqueous garlic sus-
pension by gavage, significant inhibition of cell prolifera-
tion and induction of apoptosis, as well as suppression of
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cyclooxygenase-2 (COX-2) activity, was observed [16]. The
superior chemopreventive effect of garlic on skin carcino-
genesis has also been demonstrated. Garlic induced elevated
levels of antioxidants, accompanied by decreased lipid per-
oxidation and incidences of papillomas. Garlic treatments
also downregulated COX-2 expression, a cancer progression
marker, and decreased p53 and caspase-3 expression [29].
Unlike other studies that showed a strong influence of the
bioactive compounds in garlic and tomato on the induction
of experimental tumors, such as their antioxidant activity,
it was demonstrated in this experiment that the bioactive
compounds in garlic and tomato inhibit the proliferation of
preestablished tumor cells of an experimental model consist-
ing of Ehrlich tumor-implanted tumor cells. These findings
reinforce evidence that the anti-inflammatory actions of these
substances modify the peritoneal microenvironment and
reduce other factors related to the genesis and development
of tumors, for example, reduction of neovascularization, as
these compounds can inhibit the activity of COX-2.
Indeed, it has been reported that this carotenoid is able
to inhibit edema and the inflammatory response in different
animal models by quenching singlet oxygen (1O
2
) or inhibit-
ing the generation of superoxide (O
2
−
) and nitric oxide (NO)
from inflammatory leukocytes. Additionally, 𝛽-carotene pos-
sibly inhibits prostaglandin production by negative modu-
lation of arachidonic acid oxidation via the cyclooxygenase
pathway [16, 30]. Data show that Ehrlich tumor cells trigger
an increase in prostaglandin E2 levels, which is detectable
upon peritoneal washing of mice 24 hours after tumor
implantation and remains elevated on days 6 and 10 of tumor
development [28]. Prostaglandins have many biological
effects in acute inflammation. Prostaglandin E2 is an impor-
tant mediator of inflammatory vasodilatation and markedly
potentiates the permeability and chemotactic effects of other
mediators. In fact, increased levels of prostaglandins, most
notably E2, have been detected in many malignant tumors.
𝛽-Carotene differentially modulated intercellular communi-
cation in the gap junction dependent on the dose, and this
treatment could be rather harmful at high doses [31].
In the same way, it is possible that garlic and onion exert
their anticarcinogen actions indirectly by different mech-
anisms, such as through inhibition of lipoxygenase and
cyclooxygenase activities (an anti-inflammatory effect) [12,
32].
In the current study, the number of NOR dots was signif-
icantly lower in mice treated with 6% aqueous suspensions of
garlic, tomato, and garlic + tomato than that of the control
group. The NORs are DNA segments that encode ribosomal
RNA [21]. Some nuclear proteins are associated with NORs
and are stained black with silver methods (AgNOR proteins
or AgNORs) [22]. It has been reported that AgNORs are
related to the rate of cell proliferative activity [33]. Therefore,
the decrease of AgNOR dots in groups treated with bioactive
compounds over a long term (garlic, tomatoes, and garlic +
tomato) shows that these products reduce the proliferative
activity of experimental tumors.
Cell pleomorphism and the presence of several nucleoli
and binucleated cells are also important characteristics of
a tumor malignity [34]. Although the polymorphism was
present in all cells of all groups, a greater nucleus/cytoplasm
ratio relative to the control group, which is another impor-
tant characteristic of malignant neoplastic cells, was less
frequently observed in tumor cells of mice treated with the
bioactive compounds over a long term (experiment 2).
We conclude that the aqueous suspension of garlic and/or
tomato at 6% administered orally for a long term decreased
Ehrlich tumor growth in an experimental model.
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